Article ; Online: Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms.
Drug development and industrial pharmacy
2017 Volume 43, Issue 7, Page(s) 1126–1133
Abstract: The bioavailability of the anthelminthic flubendazole was remarkably enhanced in comparison with the pure crystalline drug by developing completely amorphous electrospun nanofibres with a matrix consisting of hydroxypropyl-β-cyclodextrin and ... ...
Abstract | The bioavailability of the anthelminthic flubendazole was remarkably enhanced in comparison with the pure crystalline drug by developing completely amorphous electrospun nanofibres with a matrix consisting of hydroxypropyl-β-cyclodextrin and polyvinylpyrrolidone. The thus produced formulations can potentially be active against macrofilariae parasites causing tropical diseases, for example, river blindness and elephantiasis, which affect altogether more than a hundred million people worldwide. The bioavailability enhancement was based on the considerably improved dissolution. The release of a dose of 40 mg could be achieved within 15 min. Accordingly, administration of the nanofibrous system ensured an increased plasma concentration profile in rats in contrast to the practically non-absorbable crystalline flubendazole. Furthermore, easy-to-grind fibers could be developed, which enabled compression of easily administrable immediate release tablets. |
---|---|
MeSH term(s) | 2-Hydroxypropyl-beta-cyclodextrin ; Administration, Oral ; Animals ; Biological Availability ; Chemistry, Pharmaceutical ; Crystallization ; Mebendazole/administration & dosage ; Mebendazole/analogs & derivatives ; Mebendazole/chemistry ; Nanofibers/chemistry ; Povidone/chemistry ; Rats ; Tablets/chemistry ; beta-Cyclodextrins/chemistry |
Chemical Substances | Tablets ; beta-Cyclodextrins ; 2-Hydroxypropyl-beta-cyclodextrin (1I96OHX6EK) ; Mebendazole (81G6I5V05I) ; Povidone (FZ989GH94E) ; flubendazole (R8M46911LR) |
Language | English |
Publishing date | 2017-07 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 751874-2 |
ISSN | 1520-5762 ; 0363-9045 |
ISSN (online) | 1520-5762 |
ISSN | 0363-9045 |
DOI | 10.1080/03639045.2017.1298121 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1335: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.